Alkem Pharmaceuticals Private Limited, a struck off private limited company, was established on 06 September 1980 in Patna, Bihar, India. Engaging in other chemical product within the chemicals sector, it holds CIN: U24230BR1980PTC001473. Registered under ROC Roc Patna. it is unlisted. It has an authorized capital of ₹1.50 M and a paid-up capital of ₹0.78 M.
Its leadership includes Ashok Kumar (Director), Sarvesh Singh (Director), Nagendra Kashyap (Director). Past directors included Sarvesh Singh, Srinivas Balmiki Prasad Singh, Sarandhar Singh. Its latest AGM occurred on 30 September 2014, with the balance sheet filed on 31 March 2014. It is based at Exhibition Road P.S: Gandhi Maidan, Patna, Bihar, 800001.
U24230BR1980PTC001473
001473
06 September 1980
₹1.50 M
₹0.78 M
Roc Patna
Unlisted
Struck Off
Explore comprehensive insights into Alkem Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ashok Kumar | Director | 26 Aug 2000 | Current |
| Sarvesh Singh | Director | 28 Nov 2013 | Current |
| Nagendra Kashyap | Director | 15 Apr 1989 | Current |
| Srinivas Balmiki Prasad Singh | Director | 28 Nov 2013 | Current |
| Sarandhar Singh | Director | 28 Nov 2013 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 30 Sep 2014 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2014 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2014 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Enhance accessibility to Alkem Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Alkem Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Alkem Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Alkem Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Alkem Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Alkem Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2014 as per latest MCA records. was completed.
Alkem Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2014 with Roc Patna. was recorded as a recent event.
The activity Sarvesh Singh was appointed as a Director was appointed as a Director on 28 Nov 2013 & has been associated with this company since 12 years 1 month . was completed.
Srinivas Balmiki Prasad Singh was appointed as a Director was appointed as a Director on 28 Nov 2013 & has been associated with this company since 12 years 1 month . was recorded as a recent event.
Sarandhar Singh was appointed as a Director was appointed as a Director on 28 Nov 2013 & has been associated with this company since 12 years 1 month . was recorded as a recent event.
The activity Ashok Kumar was appointed as a Director was appointed as a Director on 26 Aug 2000 & has been associated with this company since 25 years 4 months . was completed.
Alkem Laboratories Ltd. is rebranding its APIs business as Alkem Activa to show their commitment to excellence and innovation. They want to strengthen their position in the API market and provide quality pharmaceutical ingredients. The company plans to bring in new APIs and expand its capacity with advanced technologies. Alkem Activa aims to be a trusted supplier of APIs globally and contribute to the healthcare industry..
When you make mad profits and your boss is proud but you still gotta stay humble and keep grinding. Alkem Labs reported a 124.6% increase in profit and a 15.2% increase in revenue for the June quarter. They also saw growth in their international and Indian markets, but the delayed monsoon affected sales. But don't worry, they're still killing it with their biosimilar franchise. Share price dropped by 2% though..
Alkem Labs is investing in chronic therapy and biosimilars, and scaling back on oral solids due to competition. They are focusing on cardiovascular, diabetes, and CNS therapies. The company is also expanding its field force and launching new divisions. They have invested in Enzene Biosciences for biosimilars and CDMO capabilities. Alkem is a conservative company and will wait for opportunities to evolve before making any large acquisitions..
The CIN of Alkem Pharmaceuticals Private Limited is U24230BR1980PTC001473.
Alkem Pharmaceuticals Private Limited is headquartered at Exhibition Road P.S: Gandhi Maidan, Patna, Bihar, 800001.
Alkem Pharmaceuticals Private Limited was incorporated on 06 September 1980.
The current directors of Alkem Pharmaceuticals Private Limited are
The primary industry of Alkem Pharmaceuticals Private Limited is Chemicals.
Alkem Pharmaceuticals Private Limited is unlisted.
The authorized capital of Alkem Pharmaceuticals Private Limited is ₹1.50 M, and the paid-up capital is ₹0.78 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX